Navigation Links
Vaccine to protect birds against avian flu, engineered

Researchers at the University of Pittsburgh said that they have genetically engineered an avian flu vaccine. The vaccine contains the components of the deadly strain H5N1.//

This vaccine in animal models offered complete protection to mice and chickens from infection. The vaccine contains a live virus, which is very efficient in producing an immune response than those prepared by traditional methods. It is cultured in cells and very easily produced in large amounts. It prevents the spread of the virus in domestic livestock populations and humans. The findings were published in the Journal of Virology.

Andrea Gambotto, M.D., assistant professor in the departments of surgery and molecular genetics and biochemistry, University of Pittsburgh School of Medicine, and lead author of the study said that the vaccine stimulates several lines of immunity against H5N1.

Dr. Gambotto and his colleagues genetically engineering a common cold virus (adenovirus) to express the avian influenza protein (hemagglutinin) (HA) on its surface. This virus then attaches to all the cells that are infected. Bird flu (H5N1) has affected a large number of birds in different areas like Cambodia, China, Indonesia, Japan, Laos, South Korea, Thailand and Vietnam, Turkey and Romania. Due to this 150 to 200 million birds have been culled to prevent the spread of infection.

The first incidence of bird flu attack in humans was in 1997 at Hong Kong. The virus causes severe respiratory illness resulting in death.

The adenovirus serves as vector or transporting vehicle for delivering the foreign genes or DNA of the HA protein.

Dr. Gambotto's team took two sets of mice in one set they injected the genetically engineered vaccine and in the other an adenovirus vector containing no H5N1 genes, or an empty vector. The mice immunized with the empty vector showed substantial weight loss and all were dead within six to nine days of avian flu exposure. On the other hand, most of the mice immunized with the adenovirus containing the HA protein showed only mild weight loss and survived H5N1 infection. It was also found that full length HA vaccine gave a complete protection against the H5N1 strain.

The mice which is immunized with full-length HA vaccine developed strong T-cell responses. Hence this recombinant vaccine offers a greater therapeutic value. Even if H5N1 mutates, the vaccine is still offers protection against the disease.

Based on the superior degree of protection that they found in mice vaccinated with full-length HA vaccine, Dr. Gambotto's group along with David E. Swayne, D.V.M., Ph.D., at the U.S. Department of Agriculture, tested the vaccine’s effectiveness in chickens. Chickens were injected with the vaccine and the empty vector both intranasally and subcutaneously. The chickens were then challenged with a dose of whole H5N1 virus 10,000 times greater than the dose given to the mice.

It was found that all of the chickens that were immunized subcutaneously survived exposure to H5N1 and developed strong HA-specific antibody responses and showed no clinical signs of disease. On the other hand 50% of those that were immunized intranasally died. All of the chickens immunized with the empty vector (intranasally and subcutaneously) died within two days of H5N1 exposure.

Dr. Gambotto and his colleagues suggest that these live vaccines can be used in combination with the traditional inactivated influenza vaccines.

Hence the research team concludes by saying that the new vaccine would have the ability to contain outbreaks of mutant strains. Further trails in the humans have to be conducted in order to understand the efficiency of the vaccine in humans.


'"/>




Related medicine news :

1. Vaccine to quit smoking?
2. First Vaccine Designed for Africa Cleared for Testing in Humans
3. Vaccine for Alzheimer’s diseas
4. Health Officials Recommend Flu Vaccine
5. Smallpox Vaccine May Help Fight Cervical Cancer
6. Panacea Biotech To Market Anthrax Vaccine
7. New Prostate Cancer Vaccine Shows Promise
8. Drug Firm Offers to Donate Smallpox Vaccine
9. Vaccine guards against shingles
10. Vaccine for septic conditions
11. A new Vaccine for Pneumonia
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/14/2016)... Laurel, NJ (PRWEB) , ... February 14, 2016 ... ... 14-20, 2016, the American Association of Heart Failure Nurses (AAHFN) is promoting healthier ... caregivers. This year’s campaign, Spices of Life! Healthy Living with Heart Failure will ...
(Date:2/13/2016)... ... February 13, 2016 , ... Many individuals looking to lead a healthy lifestyle ... reasons. IsoPasta by Isolator Fitness has delved into this niche allowing those giving ... high-carb repercussions. IsoPasta has 30 grams of protein and only 7 grams of ...
(Date:2/13/2016)... Salt Lake City, Utah (PRWEB) , ... February 13, 2016 , ... When an ... kids, Host Parents aren’t always sure what they are in for and they are often ... Pairs are more than they were hoping for. This year’s Au Pair of the Year ...
(Date:2/12/2016)... ... February 12, 2016 , ... The law firm of Morrow, Morrow, Ryan & ... purpose of these scholarships is to encourage applicants to pursue a degree in their ... these two parishes. , “We have available jobs in St. Landry and Evangeline ...
(Date:2/12/2016)... (PRWEB) , ... February 12, 2016 , ... Each year, ... will be held in Anaheim, CA at the Anaheim Convention Center. Almost 10,000 physical ... see new therapy products in action, learn more about their chosen field and network ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... 12 2016  OMS Supply, a large provider of ... announced today the recent launching of their new company ... of features that enhance the user experience and enable ... --> --> Despite ... company that started in early 2016, they have already ...
(Date:2/12/2016)... 12, 2016 Indiso ... den ungedeckten medizinischen Bedarf bei Lungen- und ... klinischen Forschungsprogramms bekannt. Das Programm, das sich ... ihrer respiratorischen Funktionen und anderer klinischer Parameter. ... Medizintechnikunternehmen, das sich auf den ungedeckten medizinischen ...
(Date:2/11/2016)... The primary goal of this research is to analyze ... of liquid biopsy. Key information the survey seeks to ... liquid biopsy adoption amidst future users - Predominantly used ... Sample inflow to conduct liquid biopsy tests - Preference ... on. - Correlation analysis of sample type and biomarker ...
Breaking Medicine Technology: